Coapt Systems Inc.
This article was originally published in Start Up
Coapt Systems Inc.'s Multi-Point Tension Distribution System (MTDS), an advancement over suturing, broadly disperses the tensile force generated when tissues are brought together for healing (coaptation). MTDS bioabsorbable devices will maximize the surgeon's speed and effectiveness and improving outcomes when binding soft (nontendinous) tissue to bone; tendon to tendon, bone, or muscle; in abdominal or tight skin closures; in peripheral nerve repair; or in facial suspension procedures.
You may also be interested in...
Each year more than 1.6 million patients undergo surgeries for the repair of tendons, ligaments and cartilage in the shoulder, knee and ankles. The lack of efficacy of some of past offerings in soft tissue repair has created a pent-up demand for new treatment tools.
Some medical devices can make it to the market quickly, usually in a small niche under the radar screen of large companies, and have a considerable impact. For others, there's a world of difference between getting to the market and conquering it: the difficulties of gaining market acceptance may dictate a "hurry up and wait" strategy or a slow, conservative, stepwise approach to marketing to a change-resistant medical community. The accompanying group of profiles of orthopedics/surgical device companies, whose products range from a platform for minimally invasive spine surgery with neurophysiological monitoring (NuVasive) to pyrocarbon-based small-joint replacements (Ascension Orthopedics) and superelastic memory shape alloys for anatomic braces (Springflex Orthopedics) to a soft tissue fixation system (Coapt Systems), reflects a range of commercialization strategies.
Japan has passed a new law which will require the providers of certain products to cooperate in securing supplies to the country. For the pharma industry, there are a couple of signs which specific drugs will be within the scope of the legislation and how this will impact the sector.